Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients

Blood (2023) 142 (Supplement 1): 2848.

https://doi.org/10.1182/blood-2023-180733

Published: 2023

Journal Articles

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

Blood (2021) 138 (Supplement 1): 262.

https://doi.org/10.1182/blood-2021-147709

Published: 2021

Journal Articles

Higher Grade Cytokine Release Syndrome Is a Predictive Factor for Gvhd in Haploidentical Stem Cell Transplantation with Peripheral Blood Cell

Benjamin Bouchacourt, Valerio Maisano, Ana Benzaquen, Angela Granata, Sabine Furst, Faezeh Legrand, Thomas Pagliardini, Sandrine Loron, Samia Harbi, Pierre-Jean Weiller, Marie-Joelle Mozziconacci, Claude Lemarie, Boris Calmels, Christian Chabannon, Didier Blaise, Raynier Devillier

Blood (2021) 138 (Supplement 1): 2881.

https://doi.org/10.1182/blood-2021-151187

Published: 2021

Journal Articles

Safety of Anti-NKG2A Blocking Antibody Monalizumab As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Study

Raynier Devillier, Sabine Furst, Agnes boyer Chammard, Thomas Pagliardini, Samia Harbi, Valerio Maisano, Angela Granata, Faezeh Legrand, Jihane Pakradouni, jean Marie Boher, Cyril Fauriat, Anne-Sophie Chretien, Christian Chabannon, Norbert Vey, Eric Vivier, Daniel Olive, Didier Blaise

Blood (2021) 138 (Supplement 1): 1817.

https://doi.org/10.1182/blood-2021-150730

Published: 2021

Journal Articles

Successful Clearance of Donor Specific Anti-HLA Antibodies after Desensitization with Rituximab, Velcade and Plasma-Exchange Followed By a Haploidentical Stem Cell Transplantion with Post-Transplantation Cyclophosphamide

Sabine Furst, Valerio Maisano, MD, Agnes Basire, Angela Granata, MD, Faezeh Legrand, MD, Raynier Devillier, Samia Harbi, Luca Castagna, MD, Christophe Picard, Claude Lemarie, Pharm.D., Christian Chabannon, MD PhD, Didier Blaise, MD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-142473

Published: 2020

Journal Articles

Non-Myeloablative Conditioning Regimen before T-Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Lymphoma

Blood (2019) 134 (Supplement_1): 4614.

https://doi.org/10.1182/blood-2019-128004

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

Blood (2019) 134 (Supplement_1): 4625.

https://doi.org/10.1182/blood-2019-131845

Published: 2019

Journal Articles

CMV-Seropositive Recipients Are at Higher Risk of CMV Reactivation and NRM after Haploidentical-SCT with PT-Cy

Jacopo Mariotti, Stefania Bramanti, Raynier Devillier, MD PhD, Barbara Sarina, Sabine Furst, MD, Angela Granata, MD, Valerio Maisano, MD, Thomas Pagliardini, MD, Chiara De Philippis, MD, Catherine Faucher, MD, Samia Harbi, MD, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Reda Bouabdallah, Armando Santoro, Didier Blaise, MD PhD, Luca Castagna

Blood (2019) 134 (Supplement_1): 4484.

https://doi.org/10.1182/blood-2019-125101

Published: 2019

Journal Articles

Pharmacokinetic-Guided Busulfan Based Myeloablative Versus Fixed Dose Reduced Intensity Conditioning Regimen in Patients Older Than 55 Years Undergoing Allogeneic Stem Cell Transplantation for High Risk Hematological Malignancies

Margaux Damge, Sabine Furst, MD, Bénédicte Devictor, Samia Harbi, MD, Joseph Ciccolini, Angela Granata, MD, Thomas Pagliardini, MD, Boris Calmels, Pharm.D., Claude Lemarie, Pharm.D., Luca Castagna, MD, Valerio Maisano, MD, Faezeh Legrand, MD, Anne-Marie Stoppa, MD, Reda Bouabdallah, Evelyne D'Incan, Norbert Vey, MD PhD, Christian Chabannon, MD PhD, Didier Blaise, MD PhD, Raynier Devillier, MD PhD

Blood (2019) 134 (Supplement_1): 4503.

https://doi.org/10.1182/blood-2019-125994

Published: 2019

Journal Articles

Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

Angela Granata, MD, Raynier Devillier, Stefania Bramanti, MD, Sabine Furst, MD, Faezeh Legrand, MD, Samia Harbi, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Claude Lemarie, Pharm.D., Boris Calmels, Pharm.D., Jacopo Mariotti, Valerio Maisano, MD, Pierre Jean Weiller, MDPhD, Luca Castagna, MD, Didier Blaise

Blood (2017) 130 (Supplement 1): 1984.

https://doi.org/10.1182/blood.V130.Suppl_1.1984.1984

Published: 2017

Journal Articles

Haploidentical Hematopoietic Stem Cell Allogeneic Transplantation with High Dose Post Transplantation Cyclophosphamide for Patients over 60 Years of Age

Samia Harbi, MD, Raynier Devillier, Stefania Bramanti, MD, Thomas Pagliardini, Faezeh Legrand, MD, Maud Cecile, Valerio Maisano, MD, Cecile Braticevic, Angela Granata, MD, Frederique Rousseau, Sabine Furst, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, pierre Jean Weiller, Luca Castagna, MD, Didier Blaise

Blood (2017) 130 (Supplement 1): 2035.

https://doi.org/10.1182/blood.V130.Suppl_1.2035.2035

Published: 2017

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients over 60 Years with Acute Myeloid Leukemia: A Single Center Donor Comparison

Raynier Devillier, Sabine Furst, MD, Jerome Rey, MD, Angela Granata, MD, Aude Charbonnier, MD, Samia Harbi, MD, Evelyne D'Incan, MD, Thomas Pagliardini, Catherine Faucher, MD, Claude Lemarie, Pharm.D., Colombe Saillard, MD, Faezeh Legrand, MD, Boris Calmels, Pharm.D., Bilal Mohty, MD, Valerio Maisano, MD, Christian Chabannon, MD PhD, Pierre Jean Weiller, MDPhD, Norbert Vey, Didier Blaise

Blood (2017) 130 (Supplement 1): 2038.

https://doi.org/10.1182/blood.V130.Suppl_1.2038.2038

Published: 2017

Journal Articles

Use of G-CSF after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Valerio Maisano, MD, Raynier Devillier, Sabine Furst, MD, Faezeh Legrand, MD, Samia Harbi, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Angela Granata, MD, Pierre Jean Weiller, MDPhD, Didier Blaise

Blood (2017) 130 (Supplement 1): 5536.

https://doi.org/10.1182/blood.V130.Suppl_1.5536.5536

Published: 2017

Journal Articles

Prophylactic Donor Lymphocyte Infusions after Haploidentical Hematopoietic Stem Cell Transplantation for High Risk Hematological Malignancies: A Retrospective Bicentric Analysis of Serial Infusions of Increasing Doses of CD3 + Cells

Raphaël Cauchois, Luca Castagna, MD, Samia Harbi, MD, Boris Calmels, Pharm.D., Stefania Bramanti, MD, Angela Granata, MD, Claude Lemarie, Pharm.D., Valerio Maisano, MD, Faezeh Legrand, MD, Sabine Furst, MD, Pierre Jean Weiller, MDPhD, Christian Chabannon, MD PhD, Didier Blaise, Raynier Devillier

Blood (2017) 130 (Supplement 1): 3276.

https://doi.org/10.1182/blood.V130.Suppl_1.3276.3276

Published: 2017

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis

Raynier Devillier, Jerome Rey, MD, Samia Harbi, MD, Aude Charbonnier, MD, Sabine Furst, MD, Colombe Saillard, MD, Angela Granata, MD, Evelyne D'Incan, MD, Catherine Faucher, MD, Claude Lemarie, Pharm.D., Faezeh Legrand, MD, Boris Calmels, Pharm.D., Valerio Maisano, MD, Bilal Mohty, MD, Christian Chabannon, MD PhD, Pierre Jean Weiller, MDPhD, Didier Blaise, Norbert Vey

Blood (2017) 130 (Supplement 1): 3327.

https://doi.org/10.1182/blood.V130.Suppl_1.3327.3327

Published: 2017

Journal Articles

Chimerism Analysis after Haploidentical Stem Cell Transplantation: Is It Necessary for All Patients?

Faezeh Legrand, MD, Valerio Maisano, MD, Sabine Fürst, MD, Angela Granata, MD, Marie Joelle Mozziaconacci, MD, Catherine Faucher, MD, Claude Lemarie, PharmD, Samia Harbi, MD, Christophe Picard, MD PhD, Stephania Bramanti, MD, Boris Calmels, PharmD, PhD, Christian Chabannon, MD PhD, Raynier Devillier, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 3417.

https://doi.org/10.1182/blood.V128.22.3417.3417

Published: 2016

NARROW

Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

Higher Grade Cytokine Release Syndrome Is a Predictive Factor for Gvhd in Haploidentical Stem Cell Transplantation with Peripheral Blood Cell

Safety of Anti-NKG2A Blocking Antibody Monalizumab As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Study

Successful Clearance of Donor Specific Anti-HLA Antibodies after Desensitization with Rituximab, Velcade and Plasma-Exchange Followed By a Haploidentical Stem Cell Transplantion with Post-Transplantation Cyclophosphamide

Non-Myeloablative Conditioning Regimen before T-Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Lymphoma

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

CMV-Seropositive Recipients Are at Higher Risk of CMV Reactivation and NRM after Haploidentical-SCT with PT-Cy

Pharmacokinetic-Guided Busulfan Based Myeloablative Versus Fixed Dose Reduced Intensity Conditioning Regimen in Patients Older Than 55 Years Undergoing Allogeneic Stem Cell Transplantation for High Risk Hematological Malignancies

Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

Haploidentical Hematopoietic Stem Cell Allogeneic Transplantation with High Dose Post Transplantation Cyclophosphamide for Patients over 60 Years of Age

Allogeneic Hematopoietic Stem Cell Transplantation for Patients over 60 Years with Acute Myeloid Leukemia: A Single Center Donor Comparison

Use of G-CSF after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Prophylactic Donor Lymphocyte Infusions after Haploidentical Hematopoietic Stem Cell Transplantation for High Risk Hematological Malignancies: A Retrospective Bicentric Analysis of Serial Infusions of Increasing Doses of CD3 + Cells

Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis

Chimerism Analysis after Haploidentical Stem Cell Transplantation: Is It Necessary for All Patients?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only